Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel setting
about
Real-World Corticosteroid Utilization Patterns in Patients with Metastatic Castration-Resistant Prostate Cancer in 2 Large US Administrative Claims Databases.Treatment Sequences and Pharmacy Costs of 2 New Therapies for Metastatic Castration-Resistant Prostate Cancer.Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression.A comment on the International Society of Geriatric Oncology guidelines: evidence-based advice for the clinical setting.Perspectives on treatment of metastatic castration-resistant prostate cancer.Advances in androgen receptor targeted therapy for prostate cancerDocetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines.
P2860
Q33652859-EC6B5F54-04ED-4602-8513-FCB5AF6B7A58Q35809973-D233F976-2C0A-42F6-99B6-429C345A2719Q36642876-F48D7702-230E-443D-B8F0-2A388B60768FQ36672793-765D4EB3-408D-486D-AA50-5CBE92F9BDEAQ36871685-241DA09D-308E-4CC7-801E-F4CF26FB405EQ37337217-93454AA1-D8AD-42EA-B7A2-77D1B65AA40BQ38880901-C6A80FAB-C6A4-47AC-B858-05856BAB4796
P2860
Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel setting
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel setting
@en
Novel therapeutic strategies f ...... in the post-docetaxel setting.
@nl
type
label
Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel setting
@en
Novel therapeutic strategies f ...... in the post-docetaxel setting.
@nl
prefLabel
Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel setting
@en
Novel therapeutic strategies f ...... in the post-docetaxel setting.
@nl
P2093
P2860
P1433
P1476
Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel setting
@en
P2093
Christophe Massard
Johann Sebastian de Bono
Oliver Sartor
Ross M Michels
P2860
P304
P356
10.1634/THEONCOLOGIST.2010-0412
P577
2011-11-02T00:00:00Z